Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies

NCT03588598 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia (CLL)
Small Lymphocytic Lymphoma (SLL)
B-Cell Non-Hodgkin Lymphomas(NHL)

Interventions

DRUG: SHC014748M

Sponsor

Nanjing Sanhome Pharmaceutical, Co., Ltd.